NCT07481981: A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
- State
- Under way
- Phase
- Phase 3
- People
- 344 planned
- Started
- 21 Jul 2026
- Primary completion
- 28 Dec 2028
- Arms
- Treprostinil Palmitil Inhalation Powder
- Results
- None posted
- 19 Mar 2026: Trial registered
- 21 Jul 2026: Trial started